Abstract. GABA (gamma-aminobutyric acid) receptor modulators have been investigated as a potential treatment strategy in Alzheimer's disease (AD). In the present study, we found that GABA levels were different in wild type (WT) and A␤PP/PS1 mouse brains. GABA downregulated amyloid-␤ (A␤) uptake in neurons through the receptor for advanced glycation end-products. Therefore, relative high levels of GABA decreased cytotoxicity induced by A␤ in WT mice. GABA treatment decreased basal levels of cell death and the cell death induced by hydrogen peroxide in WT and A␤PP/PS1 neurons. Application of GABA during early life before 2 months of age can improve cognitive function significantly in A␤PP/PS1 mice. However, GABA treatment at 6 and 8 months of age cannot improve water maze performance. Activating or suppressing GABA A receptors by optogenetic methods also confirmed that GABA activation before 2 months of age increased water maze performance in A␤PP/PS1 mice. Our data suggest that GABA administration during early life can be a potential treatment for AD.
INTRODUCTION
Alzheimer's disease (AD) is a neurodegenerative disease, currently with no cure. To date, the potential drug targets for AD symptomatic therapies include: acetylcholinesterase inhibitors, NMDA receptor modulators, nicotinic acetylcholine receptor activators, gamma-aminobutyric acid (GABA) receptor modulators, serotonin receptor modulators, histamine H3 receptor blockers, phosphodiesterase inhibitors, and brain metabolism enhancers [1] . There is evidence showing that GABAergic neurons are less susceptible to develop AD pathology compared with excitatory neurons [2] [3] [4] . However, there are also reports that GABA, GABA A , and GABA B receptors are downregulated in AD [5, 6] . In AD therapy trials, one selective GABA B receptor antagonist has been clinically examined in mild cognitive impairment [7] but does not demonstrate efficacy in AD [8] . The inverse agonists of the GABA A receptor benzodiazepinebinding site could improve cognition [9] . Recently, a GABA A receptor modulator, etazolate, entered a Phase II clinical trial [1] . A synthetic GABA analog 3-amino-1-propanesulfonic acid (Alzhemed, tramiprosate) is being investigated as a potential treatment for AD [10, 11] . The receptor for advanced glycation endproducts (RAGE) is a tentative cell membrane receptor for amyloid-␤ (A␤), a major component of senile plaques in AD pathology and demonstrated cytotoxic to neurons. RAGE binds to A␤ with high affinity, and in AD, upregulated expression of RAGE is reported [12, 13] . A␤ colocalizes with RAGE in the endosome [14, 15] . Preventing ligands from binding to RAGE decreases A␤ levels in the brain [15] . In rodent models, GABA A receptor antagonist, picrotoxin (Pic), rescued memory deficits in A␤PP/PS1 mice [16] . However, how GABA levels alter and how such alterations may affect animal cognition were not addressed. In this study, we aimed to determine whether GABA levels were different in wild type (WT) and A␤PP/PS1 mice and how this may influent neuronal function and cognition in these mice.
METHODS AND MATERIALS

Chemicals, peptides, siRNAs, and antibodies
GABA (Sigma, St. Louis, MO), picrotoxin (Tocris, Ellisville, Missouri), glutamate (Sigma), kainic acid (Sigma), heparin (Sigma), control IgG rabbit serum (Sigma) and H 2 O 2 (Beijing Chemicals Co., Beijing, China) were used in the experiments. All siRNAs and controls (Qiagen, Hilden, Germany) were diluted into 5 nM before injection or transfection by HiPerFect (Qiagen) as described by the manufacturer. The silencing efficiency and off-target effects of all siRNAs were verified by Qiagen. For medium absorption, pre-cleaned protein-A sepharose beads (Sigma) were coated with antibodies for overnight at 4°C and used for absorption of conditioned medium.
Tetracysteine (TC)-A␤ 1-42 peptides were dissolved in 100% DMSO and adjusted to 1 mg/ml by adding distilled H 2 O. The solutions were adjusted to pH 7.4 with 2 M Tris base. After centrifugation at 6000 g at 4 • C for 5 min, the supernatant was injected into a size exclusion chromatography column Superdex 75 HR 10/30 (GE Healthcare, Uppsala, Sweden) equilibrated with 10 mM Tris-HCl, pH 7.4. Peptides were fractionated at a flow rate of 0.5 ml/min and eluted in 1.5-column volumes. TC-A␤ 1-42 elution was monitored by UV absorbance at 210, 254, and 280 nm. Under these conditions, TC-A␤ 1-42 eluted as two well separated peaks; one corresponding to the void volume of Superdex 75 containing TC-A␤ protofibrils and the second peak corresponding to monomeric TC-A␤. The protein concentrations of the TC-A␤ fractions were estimated by using the Micro bicinchoninic acid protein assay (Pierce, Rockford, IL). The detection of TC-A␤ was performed with the TC-FlAsH™ InCell Tetracysteine Tag Detection Kits as described by the manufacturer (Invitrogen, Carlsbad, CA).
Quantum Dot (QD)-strepavidin (Jiayuan Quantum Dots Co., Wuhan, China) was incubated with A␤ 1-42 -biotin (Bachem, King of Prussia, PA) for 30 min at 37°C. The excessive QD was removed by cleaning the mixture with pre-coated beads with A␤ antibody 6E10 (Signet, Princeton, NJ). The QD-A␤ was then removed from the beads by boiling.
Cell culture
Mouse primary neurons or astrocytes were cultured from newborn WT or A␤PP/PS1 mouse hippocampus, following the regulations of Peking University Animal Care and Use Committee. In brief, fresh mouse hippocampal tissues were dissociated with 0.25% trypsin (Invitrogen), which was then inactivated by 10% decomplemented fetal bovine serum (FBS, HyClone, Logan, UT). The mixture was triturated through pipette to make a homogenous mixture. After filtering the mixture through 70 m sterilized filters, the flow-through was centrifuged. The pellet was then washed once by phosphate buffered saline (PBS) and once by Dulbecco's modified Eagle's medium (DMEM) containing 0.225% sodium bicarbonate, 1 mM sodium pyruvate, 2 mM L -glutamine, 0.1% dextrose, 1× antibiotic PenStrep (all from Invitrogen) with 5% FBS. Cells were then plated on poly-L -lysine (Sigma) coated plates or glass coverslips at the density of 1 × 10 5 cells/ml. Neurons were incubated at 37°C in DMEM without phenol red with 5% FBS and with 5% circulating CO 2 . Cytarabine was added to culture media 24 h after plating at 10 M to inhibit dividing cell growth. Medium was changed every 48 h. Cells were treated for experiments at 7 days in culture.
Adeno-virus infection
ChR2 and eNpHR cDNAs were subcloned from pEGFP-N3 into pAdTrack with BglII and XhoI digestions. Adeno-virus was packaged in HEK293 cells and the infectious particle was measured as 2 × 10 6 particles/ml (MOI = 1.33). To infection of cell cultures, the purified virus supernatant was added to cell culture medium at the dilution of 1 : 500 for 24 h.
Microinjection
Thin-walled Borosilicate glass capillaries (outer diameter = 1.0 mm, inner diameter = 0.5 mm) with microfilament (MTW100F-4, World Precision Instrument, Sarasota, FL) were pulled with a Flaming/Brown Micropipette Puller (P-97, Sutter, Novato, CA) to obtain injection needles with a tip diameter of 0.5 m. Microinjections were performed in the cytosol of each cell using the Eppendorf Microinjector FemtoJet and Eppendorf Micromanipulator (Eppendorf, Hamburg, Germany). Neurons were injected with 25 fl/shot at an injection pressure of 100 hPa, a compensation pressure of 50 hPa, and an injection time of 0.1 s. All siRNAs and controls (Qiagen) were diluted into 5 nM before injection. The silencing efficiency and off-target effects of all siRNAs were verified by Qiagen. The solutions were injected at the indicated concentrations with 100 g/ml dextran Texas Red (MW: 3000, Molecular Probes, Eugene, OR) as a fluorescent marker to recognize the injected cells. Approximately 90% neurons survive the injections for at least 16 days [17] .
Electrophysiology recording
Whole-cell patch-clamp recordings were acquired from rat cultured hippocampal neurons 24 h postinfection using standard whole-cell patch-clamp techniques [18] . Patch pipettes were pulled from thinwalled borosilicate glass (Sutter Instruments) with a micropipette puller (P-2000; Sutter) to a resistance of 3-5 M . A MultiClamp 700B amplifier (Axon Instrument) was used, and currents were low-pass filtered at 1 kHz and then digitalized on-line at 10 kHz using a Digidata 1440A (Axon Instrument). Data was acquired and stored with the use of pClamp-10 software (Axon Instrument). Photocurrents were measured while holding neurons in voltage clamp at −65 mV. Whole-cell capacitance and series resistance was measured from the amplifier, and compensation was adjusted to 80%. For whole cell patch-clamp studies, the standard extracellular solution contained (in mM) 125 NaCl, 2 KCl, 3 CaCl 2 , 1 MgCl 2 , 30 glucose, and 25 HEPES (pH = 7.3 with NaOH). The recording pipette solution consisted of (in mM) 97 potassium gluconate, 38 KCl, 0.35 EGTA, 20 HEPES, 4 magnesium ATP, 0.35 sodium GTP, and 6 NaCl (pH 7.25 with KOH). For all experiments, raw data were analyzed and plotted using Origin 7.5 software (Microcal Software).
Optical stimulation
DG-4 high-speed optical switch with 300-W xenon lamp (Sutter Instruments) was used to deliver the light pulses for ChR2 activation. This system could steer laser beam at a maximum rate of 10 ms per site, and formed any flexible pattern of stimulation, with the help of image acquired by the CCD camera. Basically the laser beam was steered with a two-dimensional acousto-optic deflector, so the intensity and dwell time at each site could be finely tuned [19, 20] .
Calcium imaging
Intracellular Ca 2+ levels were measured by cellpermeable Ca 2+ sensitive fluorescent dye, fura-2/ acetoxymethyl ester (AM) (Invitrogen). Cells were first washed with PBS, and then loaded with 5 M fura-2/AM for 10 min at 37 • C. The dye was washed by artificial cerebrospinal fluid (ACSF), and the cells were loaded with ACSF for fluorescence stimulation. The ratio of the fluorescence emitted at the two excitation wavelengths (340 nm/380 nm), and the same emission wavelength (510 nm), were monitored 200 ms for each group, measuring three times for the average value. The ratio of fluorescence intensity (F340/F380) excited at 340 nm and 380 nm was monitored as a quantitative index of intracellular [Ca 2+ ], which was independent of the fura-2 concentration.
Morris water maze
Animal treatments
Male WT or A␤PP/PS1 mice, 20-30 g of body weight, were used in water maze experiments. Mice were housed under constant temperature and humidity conditions on a 12 h light/12 h dark cycle with food and water available. All mice were anesthetized with 10% chloral hydrate solution (4 ml/kg, i.p.) or ethyl carbamate solution (1.5 g/kg, i.p.) and placed in a stereotaxic instrument with the skull horizontal for surgery. The injection site for adult mice was determined as follows by using the position of the Interaural as reference: anteroposterior, −1.5 mm; lateral, −2.0 mm; ventral, −2.0 mm (from dura). The injection site for the postnatal day 0 (P0) pups was estimated similarly in anteroposterior, lateral, and ventral coordinates. One week after the surgery, treatments were applied: 3 mM GABA or 3 mM Pic in 1 l of solution was injected into each hippocampus over a 2-min period through a Hamilton microsyringe and the needle was left in place for additional 3 min. The injection was carried out for 5 successive days.
Water maze tests
Morris water maze apparatus consisted of a circular swimming pool measuring 120 cm in diameter and 50 cm in height. It was placed in a room where many extra-maze cues were available on the walls. The pool was filled to a depth of 30 cm with 21-22 • C water. The hidden platform top was a circular plate measuring 10 cm in diameter. The hidden platform was located 2 cm below the water surface. On the second day, mice were trained to escape onto the hidden platform in the water maze. The pool was conceptually divided into four quadrants with equal area size. The hidden platform was placed in the center of one of the quadrants throughout the experiment. Each of the four cardinal points of perimeter of the pool was used randomly as a starting location. Before the experiment, the times mice spent in each quadrant (including the target quadrant) without the platform placed were recorded. A trial began when a mouse was placed in the pool facing the wall and ended when the mouse escaped onto the platform. The escape latency to the platform was recorded. If a mouse failed to escape within 60 s, the trial was terminated and the escape latency was defined as 60 s, and the mouse was guided to the platform by the experimenter. Mice were given 4 trials per day for 5 consecutive days (total 20 trials). At the 6th day, a probe trial test was carried out by recording the times spent in each quadrant without a platform.
Immunocytochemistry
Cells were permeablized in PBS-Triton at 4 • C, blocked 10% donkey serum at room temperature, followed by incubation with anti-GAD67 (R&D System, Minneapolis, MN, 1 : 500) or anti-GABA A receptor (R&D System, 1 : 500) at 4 • C for 24 h. Cy2 or Cy3-conjugated donkey anti-rabbit antibody was applied as the secondary antibody. The nuclei were then staining by Hoechst 33258 (1 g/ml, Sigma) for 15 min in dark. The coverslips were mounted with Immunon TM mounting medium (Shandon, Pittsburgh, PA) onto glass slides the results were analyzed by using fluorescence microscope (Olympus BH2-RFCA, Olympus, Tokyo, Japan) with digital camera (Olympus DP70 Digital Microscope Camera, Olympus).
Liquid chromatography-mass spectrometry (LC-MS/MS)
Hippocampal neurons from both the WT and transgenic mice were cultured for 7 days in vitro. The medium was collected. The cerebrospinal fluid (CSF) was collected from the hippocampus regions at the indicated age. The samples were labeled with iTRAQ reagents (AA 45/32 kit, Applied Biosystems, Beijing, China) as recommended by the manufacturer and analyzed on an Applied Biosystems 3200 Q TRAP LC/MS/MS system equipped with a RP-C18-column (150 mm length, 4.6 mm diameter, 5 mm particle size).
Measurement of neuronal cell death
Cells were fixed in fresh 4% paraformaldehyde, 4% sucrose in PBS for 20 min at room temperature and permeablized in 0.1% Triton X-100, 0.1% sodium citrate in PBS for 2 min on ice. Terminal deoxynucleotidyl transferase-biotin dUTP nick-end labeling (TUNEL) staining was performed using the in situ cell death detection kit I as described by the manufacturer (Roche, Quebec, Canada). The coverslips were then washed once in distilled water for 5 min and mounted on glass slides to be observed under a fluorescence microscope. For the non-injected cells, the percentage of cell death was determined by the ratio of the number of TUNEL-positive cells over the total of 100 cells in one count. The average of 5 counts was calculated as the percentage of neuronal cell death in a certain treatment.
The cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), which correlates cell number with mitochondrial reduction of MTT to a blue formazan precipitate [21] . In brief, cells were plated in 96-well plates beforehand. The medium was then replaced with fresh medium containing 1 mg/ml MTT. Following incubation at 37 • C for 4 h, the wells were aspirated, the dye was solubilized in DMSO and the absorbency was measured at 595 nm. The viability of cells was compared with that of control cells. Lactatedehydrogenase (LDH) release was measured using the LDH Cytotoxicity Detection Kit (Roche, Quebec, Canada) according to the manufacturer's instructions.
Real-time PCR
Cells were harvested and total RNA was isolated with TRIGene reagent (GenStar BioSolutions Co., Ltd., Beijing, China). Total RNA (2 g) were reversely transcribed using TransScript II First-Strand cDNA Synthesis SuperMix (Beijing TransGen Biotech Co., Ltd., Beijing, China). Real-time PCRs were done by using TransStart Green q PCR SuperMix UDG (Beijing TransGen Biotech Co., Ltd.). Sequences of primers for mouse RAGE used were as following: forward: (5 -GCCTGTCGTGGACTTGGT-3 ); and reverse: (5 -TTCCGATGTTCAGAATGATGTT-3 ). Real-time PCR quantifications were run in triplicate for each sample and the average were determined. In order to use the comparative Ct method for relative quantification, the amplification efficiency of target and housekeeping gene must be approximately equal. Quantification was done using the comparative Ct method, expression levels for the target gene was normalized to the GAPDH of each sample 
Enzyme-linked immunosorbent assay (ELISA)
ELISA was used to determine the concentrations of A␤. Conditioned culture medium was collected and kits for determine mouse and human A␤ (R&D System, Minneapolis, MN) were used to measure their concentrations described by the manufacturer. Then the relative optical intensity of each well was read out by microplate reader BioRad 480 (BioRad, Hercules, CA).
Western blots
Neuronal proteins were extracted in the cell lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1% NP-40, 0.1% SDS) and protein concentrations were measured by bicinchoninic acid assay (Pierce, Rockford, IL). Protein extracts were denatured at 100°C for 5 min and separated on 15% sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) at 70 volts for about 2 hour. Proteins were transferred to Immobilon-P ™ polyvynilidene fluoride (PVDF) membrane (Millipore, Billerica, MA) at 100 milliamps for 2 h. The membrane was blocked with 5% non-fat milk in Tris buffered saline (TBS) with 0.1% tween20 (TBS-T) at room temperature for 1 h. Anti-RAGE (Abcam, Cambridge, UK) and anti-GAPDH (Sigma) antibodies were diluted at 1 : 1000 for Western blots as primary antibodies. After 3 washes of 10 min each with TBS-T, goat anti-rabbit IgG conjugated with horseradish peroxidase (HRP) was added in a dilution of 1 : 2500 as the secondary antibody. The secondary HRP was detected by enhanced chemiluminescence. Optical density was analyzed by BioRad ChemiDox (BioRad).
Statistical evaluation
Statistical significance was assessed by one-way analysis of variances (ANOVA). The Sheffé's test was applied as a post hoc for the significant difference shown by ANOVAs. A p value of less than 0.05 was used as an indicative of statistical significance.
RESULTS
GABA decreased extracellular Aβ uptake
In the present study, in A␤PP/PS1 mice at birth, compared with WT, there were no significant differences in the number of GAD67 positive neurons or GABA A receptor positive neurons observed in hippocampal neuronal cultures (Fig. 1A, B) . However, the levels of GABA were remarkably lower in A␤PP/PS1 mouse hippocampal neurons in culture (Fig. 1C, left  panel) or CSF collected from hippocampus regions (Fig. 1C, right panel) at 0, 2, 6, and 8 months old compared to age-matched WT mice (Fig. 1C) . This led us to hypothesize that the dramatic difference of GABA levels in the hippocampus between A␤PP/PS1 and WT mice played an important role in AD pathology development.
We then investigated whether GABA altered the levels of A␤ in cultured neurons. We first examined the levels of endogenous A␤ in culture medium in WT rat hippocampal neurons. With the presence of GABA (1 M) for 6 h, endogenous A␤ 1-42 increased significantly ( Fig. 2A, top panel) . GABA A receptor antagonist picrotoxin (10 M) reversed this effect ( Fig. 2A, top panel) . To further determine if the increased A␤ levels were due to the upregulation of A␤ production or the downregulation of A␤ uptake, synthesized human A␤ 1-42 was added to the culture medium. The data from ELISA specifically for human A␤ showed that synthesized human A␤ also increased with GABA treatment at 6 h and 24 h ( Fig. 2A) indicating that the enhanced A␤ levels may due to the downregulation of A␤ uptake induced by GABA. To further confirm this, exogenous human A␤ 1-42 labeled with TC or QD were added to the culture medium. The amounts of TC-and QD-A␤ inside of neurons were measured and the data showed that both TC-and QD-A␤ in the cells decreased remarkably with GABA treatment, whereas picrotoxin 640 X. Sun et al. / GABA Regulates Amyloid Uptake Fig. 1 . GABA levels were downregulated in A␤PP/PS1 mice. A, B) Immunocytochemistry staining in cultured neurons showed that there were about 20% GABAergic neurons in the hippocampus from both WT and A␤PP/PS1 mice. Scale bar: 100 m. C) GABA levels were downregulated in A␤PP/PS1 mice in the medium of cultured neurons and the CSF from 2, 6, and 8 months old animals. Data represented mean ± SE (every experiment was repeated for 3 times). **p < 0.01, compared with WT group. reversed such downregulation ( Fig. 2A) , suggesting that GABA induced downregulation on A␤ uptake in neurons, which was mediated by GABA A receptors.
To exclude the possibility that the exogenous GABA applied was not physiological relevant, we then stimulated endogenous GABAergic neurons with optogenetic system (Fig. 2B) . In brief, light-activated receptor ChR2 under GAD67 promoter was transduced into cultured mouse hippocampal neurons with adenovirus. The colocalization of GABA and EGFPChR2 (Fig. 2C) indicated that the target GABAergic neurons were successfully infected. When activated by ∼470 nm wavelength blue light (Fig. 2B) , ChR2 opened allowing Na + or Ca 2+ to flow into the neuron. The neuron was activated and could fire action potential [20, 22] . After activating GABAergic neurons by light, endogenous and added human A␤ in the culture medium increased dramatically (Fig. 2D) , whereas the uptake of TC-and QD-A␤ 1-42 decreased (Fig. 2D) suggesting that GABA released endogenously could also induce downregulation of A␤ uptake. As controls, the uptake of EGFP alone or the labeled reversed peptide QD-A␤ 42-1 with or without GABA stayed unchanged (Fig. 2E) . In the cultured A␤PP/PS1 mouse hippocampal neurons, the downregulation of A␤ uptake induced by GABA was much more potent than in the WT mouse neurons (Fig. 2F,  top panel) . To compare, glutamate (10 M) and kainic acid (10 M) did not induce significant alterations in A␤ uptake in both WT and A␤PP/PS1 mouse neurons (Fig. 2F, middle panel) suggesting that GABA might not decrease A␤ uptake by modulating neuronal excitability. The results from QD-A␤ 1-42 also confirmed that GABA downregulated A␤ uptake at a higher level in A␤PP/PS1 mouse neurons than in WT mouse neurons (Fig. 2F, bottom panel) .
GABA decreased Aβ uptake by downregulating RAGE
To further investigate the mechanism of GABAinduced downregulation of A␤ uptake, we first examined if RAGE, a potential binding protein on cell membrane mediating A␤ endocytosis [13] , was involved. Immunostaining data showed that, in cultured rat neurons, exogenously added human A␤ colocalized with RAGE and endosome (Fig. 3A) suggesting that A␤ could be uptaken by RAGE. After verifying the knockdown efficiency of two siRNAs for RAGE in cultured neurons (Fig. 3B) , these siRNAs were microinjected into neurons with or without Fig. 2 . GABA decreased A␤ 1-42 uptake. A) In cultured hippocampal neurons from WT mice, GABA (1 M) induced a decrease of A␤ uptake indicated by endogenous A␤ , exogenous human A␤ 1-42 (hA␤ ), TC-hA␤ , and QD-A␤ . Picrotoxin (10 M) reversed the effects of GABA. B) Apparatus of optogenetics was used to activate neurons with blue light. C) Cultured hippocampal neurons from WT mice were infected with adeno-virus packaged with GAD67::ChR2. Immunostaining showed that transduced neurons (EGFP) overlapped with GAD-positive neurons. Scale bar: 100 m. D) These neurons were then activated by blue light to induce endogenous GABA release. With light activation, A␤ 1-42 uptake was reduced. E) As controls, uptake of EGFP or QD-A␤ 42-1 was not altered by GABA application. F) In cultured hippocampal neurons from both WT and A␤PP/PS1 mice, GABA decreased A␤ uptake with more dramatic effects in A␤PP/PS1. Data represented mean ± SE (every experiment was repeated for 3 times). *p < 0.05, **p < 0.01, compared with control group. Fig. 3 . RAGE and Ca 2+ signaling were involved in GABA downregulation of A␤ uptake. A) Co-localization of RAGE, uptaken exogenous hA␤ , and endosome in cultured hippocampal neurons from WT mice. B) Two siRNAs (RNAi-1, RNAi-2) could efficiently knockdown RAGE expression when transfected into astrocytes of WT mice. C) In cultured neurons from WT mice, siRNAs to RAGE (microinjected), RAGE antibody (applied to medium), control IgG (applied to medium), and RAGE antagonist heparin (applied to medium) blocked downregulation of A␤ uptake induced by GABA, suggesting that RAGE was involved in GABA mediated A␤ uptake modification. D) GABA did not induce changes in RAGE mRNA levels. E) GABA increased s-RAGE and decreased full-length RAGE levels. F, G) GABA increased Ca 2+ signaling and intracellular Ca 2+ concentrations in cultured WT neurons. Scale bar: 200 m. Data represented mean ± SE (every experiment was repeated for 3 times). *p < 0.05, **p < 0.01, compared with control group. the presence of GABA. Our data showed that when RAGE was knocked down by siRNAs, GABA did not induce decrease in A␤ uptake indicating that RAGE was involved in A␤ uptake (Fig. 3C) . Similarly, neutralizing antibody to RAGE [23] applied to the culture medium (25 g/ml) greatly reduced the downregulation of A␤ uptake induced by GABA, whereas control rabbit serum IgG (25 g/ml) did not have such effect (Fig. 3C) . Furthermore, RAGE antagonist heparin (2 g/ml) blocked GABA downregulation of A␤ uptake suggesting RAGE played a critical role in A␤ uptake (Fig. 3C) .
To further examine if GABA regulated A␤ uptake by modulating RAGE expression level, RT-PCR was performed with or without GABA presence in the cultured neurons. Our results showed that GABA did not alter RAGE mRNA level (Fig. 3D) . RAGE can be posttranscriptional processed into full-length or soluble forms (s-RAGE) [24] . Western blot data showed that with GABA treatment, s-RAGE increased whereas full-length cell membrane-located RAGE decreased (Fig. 3E) , which may contribute to decreased binding to A␤ and therefore, downregulation of A␤ uptake. We observed that GABA increased cellular Ca 2+ concentration dramatically (Fig. 3F, G) , which may increase the secretion of s-RAGE and decrease the level of cell membrane-located RAGE, and therefore, downregulate A␤ uptake.
Early GABA application increased cell viability and improved cognitive functions
Noticing that GABA could decrease A␤ uptake, we then explored the physiological functions and implications of such regulation. In the cultured WT mouse neurons, cell death/viability assays, including MTT, LDH release, and TUNEL, showed that GABA application increased cell viability through GABA A receptors (Fig. 4A) , which could be reversed by RAGE neutralizing antibody and its antagonist heparin (Fig. 4B) , indicating that GABA treatment improved cell viability mediating by RAGE. In cultured hippocampal neurons from newborn WT or A␤PP/PS1 mice, GABA greatly decreased cell death induced by insult H 2 O 2 (Fig. 4C) . In A␤PP/PS1 mice, there was a higher background cell death at 0, 2, 6, and 8 months of age compared to WT mice in hippocampus (Fig. 4D) . Injection of GABA (3 mM, 1 l) to hippocampus at 0 and 2 months of age reduced cell death in A␤PP/PS1 mice (Fig. 4D) . However, interestingly, application of GABA at later age of 6 or 8 months did not induce any protective effects (Fig. 4D) .
To further investigate the implication of GABA application in early life on cognitive functions, we injected GABA into the hippocampus CA1 region of WT and A␤PP/PS1 mice at 0, 2, 6, and 8 months of age and observed the performance of spatial memory with Morris water maze test. GABA application at 0 and 2 months significantly improved cognitive performance of A␤PP/PS1 mice (Fig. 5A, B) . In contrast, GABA application at 6 or 8 months of age did not improve water maze performance in A␤PP/PS1 mice (Fig. 5C, D) . Since evidence showed that the anesthetic we used in this study (chloral hydrate) could activate GABA A receptors [25] , we also used another anesthetic (ethyl carbamate) to exclude the possible effects to GABA system induced by anesthesia. Our data showed that there was no significant difference on water maze performance between two anesthetics applied in the presence or absence of GABA at the age of 0 (Fig. 5E) or 6 (Fig. 5F ) months. To confirm that endogenous GABA could improve cognitive functions, optogenetic activation of GABAergic neurons was used. The hippocampus CA1 regions of either WT or A␤PP/PS1 mice were infected with adenovirus packaged with GAD67::ChR2 or GAD67::eNpHR. The efficiency of optogenetics system was examined in cultured hippocampal neurons from WT mice by patch clamping (Fig. 6A) . Voltage traces showed membrane depolarization and spikes in a current-clamped hippocampal neuron infected with ChR2 evoked by blue light pulses (Fig. 6B , top: 5 ms 4 Hz; bottom left: 5 ms 10 Hz; bottom right: 5 ms 20 Hz). Ten overlaid current traces were recorded from one neuron illuminated with 500 ms light pulses (indicated by blue bars), separated by intervals varying from 1 s to 10 s (Fig. 6C ). With light produced by an optical fiber into the hippocampus of the live animal (Fig. 6D) , the excitatory ChR2 (by ∼470 nm blue light) or inhibitory eNpHR (by ∼580 nm yellow light) was activated and the GABAergic neurons in the hippocampus were "turned on or off" by the light. Our data showed that activating GABAergic neurons at 2 months of age in A␤PP/PS1 mice improved their cognitive defects significantly (Fig. 6E,  F) , whereas "turning on" GABAergic neurons in later life at 6 months did not rescue the cognitive impairment in A␤PP/PS1 mice (Fig. 6G, H) .
DISCUSSION
In our present study, we report that in A␤PP/PS1 mice, GABA levels in the hippocampus are remarkably lower than WT control mice at birth, 2 months, Fig. 4 . GABA reduced cell death in both WT and A␤PP/PS1 mice. A) GABA increased cell viability (indicated by MTT assays) and reduced cell death (indicated by LDH release and TUNEL assays) in cultured hippocampal neurons from WT mice. B) RAGE was involved in GABA protective effects. C) With H 2 O 2 stress, GABA reduced cell death in both WT and A␤PP/PS1 mouse neurons. D) In the brain tissue slices, GABA reduced cell death in new born and 2 month old A␤PP/PS1 mice, but not 6 and 8 months old A␤PP/PS1 mice. Data represented mean ± SE (every experiment was repeated for 3 times). **p < 0.01, compared with control group. 6 months, and 8 months of age. GABA increases the formation of soluble RAGE and decreases the levels of full-length RAGE and therefore lowers A␤ uptake by RAGE. Exogenous GABA application or activation at birth or at 2 months, but not at 6 or 8 months, improves cognitive impairment in A␤PP/PS1 mice. We propose the following mechanism of GABA regulation. In A␤PP/PS1 mice, GABA level is greatly reduced by the unknown mechanism. GABA is a neurotransmitter and may affect Ca 2+ signaling in neurons [11] . Less GABA binds to GABA A receptors at the postsynaptic site and induces less Ca 2+ influx, which then leads to lower level of s-RAGE and higher level of cell membrane-located full-length RAGE. Calcium concentration has been demonstrated to be essential to intramembrane proteolysis of RAGE and sRAGE production [26] . Calcium chelator EGTA added in the culture medium decreases sRAGE levels [26] . In the other hand, thapsigargin, a specific sarco-endoplasmic reticulum calcium-ATPase inhibitor, which liberates calcium from the endoplasmic reticulum and leads to calcium accumulation in the cytoplasm, increases sRAGE production [26] . In our proposed model, more cell surface RAGE binds to A␤ and induces more endocytosis of A␤. Cellular A␤ is extremely toxic to neurons and triggers cell death [27] . Therefore, in WT mice, relatively higher level of GABA protects neurons against cell death (Fig. 7A, B) . Our results also indicate that GABA decreases A␤ uptake and therefore improves cell viability in cultured neurons, and its application during early life (0-2 months) can reverse the cognitive impairment in A␤PP/PS1 mice. In A␤PP/PS1 mice, there are several reagents or factors reported to have the potential to reverse the cognitive impairment. Pyrrolidine dithiocarbamate taking orally improves spatial learning through Akt pathway in 7 months old mice [28] . Cholesterol and docosahexenoic acid alter cognition in 8 and 15 months old mice [29] . Granulocyte colony stimulating factor reverses cognitive impairment in 7-9 months old animals [30] . Anti-PrP C monoclonal antibody 6D11 decreases errors in 8 months mice in behavioral tests [31] . Overexpression of human apolipoprotein A-I in the circulation prevents learning and memory deficits [32] . Liver X receptor agonist GW3965 improves cognition in novel object recognition memory through ATP-binding cassette transporter A1 [33] . In the present study, we find that in A␤PP/PS1 mice, stimulating endogenous GABAergic neurons is effective enough to reverse the cognitive impairment. It is still unclear why late life GABA application does not have protective effects. It is reported that in 9-15 months old A␤PP/PS1 mice, GABA A receptor antagonist bicuculline increases long-term potentiation levels and another GABA A receptor antagonist picrotoxin, at a non-epileptic dose, rescues memory deficits [16] . In Fig. 7 . Schematic drawing of GABA reduced cell death through decreasing A␤ uptake via RAGE. A, B) In A␤PP/PS1 mice, GABA level was greatly reduced by the unknown mechanism. Less GABA binded to GABA A receptors at the postsynaptic site and induced less Ca 2+ influx, which then lead to lower level of s-RAGE and higher level of cell membrane-located RAGE. More cell surface RAGE binded to A␤ and induced more endocytosis of A␤, which led to cognitive impairment. this study, the authors link reduced long-term potentiation and cognitive dysfunction to enhanced GABA inhibition induced by aging and familial AD mutations [16] . It is possible that GABA treatment in adult life may switches from "not enough GABA signaling" to "too much GABA inhibition". Therefore, in the adult A␤PP/PS1 mice, no significant cognitive improvement was observed in this study. It is also reported that although GABA is an inhibitory neurotransmitter in adult animals, it is excitatory during early life and development [34] . Therefore, it is possible that GABA plays distinct roles in early life from in late life. Our data suggest that there is a remarkable difference in GABA levels in WT and A␤PP/PS1 mice. It is possible that during development and early life, different micro-environment such as local GABA concentration produces vulnerability of neurons to external insults, such as A␤. Our results provide a new perspective for AD therapy and prevention.
